Evidence map›Paper›PMID 40053730›Full record

ArticleJournal of medical Internet research2025

Characterizing Public Sentiments and Drug Interactions in the COVID-19 Pandemic Using Social Media: Natural Language Processing and Network Analysis.

Wanxin Li, Yining Hua, Peilin Zhou, Li Zhou, Xin Xu, Jie Yang

Abstract read
In one paragraph

Article in Journal of medical Internet research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Wanxin LiSchool of Public Health, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.ORCID 0000-0002-7981-3228
Yining HuaDepartment of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, United States.ORCID 0000-0001-7779-1208
Peilin ZhouThrust of Data Science and Analytics, Hong Kong University of Science and Technology, Guangzhou, China.ORCID 0000-0001-6763-5236
Li ZhouDivision of General Internal Medicine and Primary Care, Department of Medicine, Brigham and Women's Hospital, Boston, MA, United States.ORCID 0000-0003-3874-4833
Xin XuSchool of Public Health, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.ORCID 0000-0002-4639-6480
Jie YangSchool of Public Health, the Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.ORCID 0000-0001-5696-363X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundWhile the COVID-19 pandemic has induced massive discussion of available medications on social media, traditional studies focused only on limited aspects, such as public opinions, and endured reporting biases, inefficiency, and long collection times.

objectiveHarnessing drug-related data posted on social media in real-time can offer insights into how the pandemic impacts drug use and monitor misinformation. This study aimed to develop a natural language processing (NLP) pipeline tailored for the analysis of social media discourse on COVID-19-related drugs.

methodsThis study constructed a full pipeline for COVID-19-related drug tweet analysis, using pretrained language model-based NLP techniques as the backbone. This pipeline is architecturally composed of 4 core modules: named entity recognition and normalization to identify medical entities from relevant tweets and standardize them to uniform medication names for time trend analysis, target sentiment analysis to reveal sentiment polarities associated with the entities, topic modeling to understand underlying themes discussed by the population, and drug network analysis to dig potential adverse drug reactions (ADR) and drug-drug interactions (DDI). The pipeline was deployed to analyze tweets related to the COVID-19 pandemic and drug therapies between February 1, 2020, and April 30, 2022.

resultsFrom a dataset comprising 169,659,956 COVID-19-related tweets from 103,682,686 users, our named entity recognition model identified 2,124,757 relevant tweets sourced from 1,800,372 unique users, and the top 5 most-discussed drugs: ivermectin, hydroxychloroquine, remdesivir, zinc, and vitamin D. Time trend analysis revealed that the public focused mostly on repurposed drugs (ie, hydroxychloroquine and ivermectin), and least on remdesivir, the only officially approved drug among the 5. Sentiment analysis of the top 5 most-discussed drugs revealed that public perception was predominantly shaped by celebrity endorsements, media hot spots, and governmental directives rather than empirical evidence of drug efficacy. Topic analysis obtained 15 general topics of overall drug-related tweets, with "clinical treatment effects of drugs" and "physical symptoms" emerging as the most frequently discussed topics. Co-occurrence matrices and complex network analysis further identified emerging patterns of DDI and ADR that could be critical for public health surveillance like better safeguarding public safety in medicines use.

conclusionsThis study shows that an NLP-based pipeline can be a robust tool for large-scale public health monitoring and can offer valuable supplementary data for traditional epidemiological studies concerning DDI and ADR. The framework presented here aspires to serve as a cornerstone for future social media-based public health analytics.

Indexed as

COVID-19COVID-19 Drug TreatmentNatural Language ProcessingSocial MediaAdenosine MonophosphateAlanineAntiviral AgentsDrug InteractionsHumansPandemicsSARS-CoV-2Adenosine MonophosphateAlanineAntiviral AgentsremdesivirCOVID-19drugsnatural language processingpharmacovigilancepublic healthsocial media

Identifiers

PMID40053730
PMCPMC11923463

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.